{"id":"aromatase-inhibitors-non-steroideal","safety":{"commonSideEffects":[{"rate":"20-30%","effect":"Joint pain"},{"rate":"15-25%","effect":"Hot flashes"}]},"_chembl":{"chemblId":"CHEMBL5760702","moleculeType":null,"molecularWeight":"276.36"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"These inhibitors specifically target the aromatase enzyme, which is responsible for converting androgens into estrogens. By inhibiting this enzyme, they effectively lower estrogen levels, which can slow the growth of hormone-sensitive breast cancers.","oneSentence":"Non-steroidal aromatase inhibitors block the enzyme aromatase, reducing estrogen production in postmenopausal women.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:29:15.984Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hormone receptor-positive, HER2-negative early breast cancer in postmenopausal women"},{"name":"Advanced or metastatic breast cancer in postmenopausal women"}]},"trialDetails":[{"nctId":"NCT03944434","phase":"PHASE2","title":"FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Sandro Pitigliani","startDate":"2018-12-27","conditions":"Breast Cancer","enrollment":116}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Femara","Arimidex"],"phase":"phase_2","status":"active","brandName":"Aromatase Inhibitors, non steroideal","genericName":"Aromatase Inhibitors, non steroideal","companyName":"Fondazione Sandro Pitigliani","companyId":"fondazione-sandro-pitigliani","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Non-steroidal aromatase inhibitors block the enzyme aromatase, reducing estrogen production in postmenopausal women. Used for Hormone receptor-positive, HER2-negative early breast cancer in postmenopausal women, Advanced or metastatic breast cancer in postmenopausal women.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}